한국어
English
日本語
中文(简体)
Deltiva Tablets 50 mg (Delamanid)
50mg
Tablet · Prescription medication
Otsuka Pharmaceutical Co., Ltd.
Delamanid is an anti-tuberculosis agent used to treat tuberculosis by inhibiting the growth of Mycobacterium tuberculosis.
MFDS ingredient code M260607
Delamanid is a drug of the anti-tuberculosis class used in the treatment of tuberculosis. This ingredient is included in pharmaceuticals with the purpose of interfering with the synthesis of the cell wall of Mycobacterium tuberculosis, thereby inhibiting the growth of the bacteria. It is mainly utilized in the treatment of multidrug-resistant tuberculosis.
Delamanid disrupts the process of creating the cell wall, which is essential for the survival of Mycobacterium tuberculosis. As a result, the bacteria cannot proliferate normally and eventually die. Therefore, it effectively suppresses tuberculosis infections.
Approved uses differ by product. Check each product's information for its actual use.
Delamanid possesses a unique mechanism of action that is different from conventional anti-tuberculosis agents, making it effective against multidrug-resistant strains of tuberculosis. It helps reduce resistance issues when used in combination with other anti-tuberculosis medications.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.